Carl D Langefeld

No ORCID on file · 4 papers in corpus
review 2023
Pain ·doi:10.1097/j.pain.0000000000002938

Chronic pain affects more than 50 million Americans. Treatments remain inadequate, in large part, because the pathophysiological mechanisms underlying the development of chronic pain remain poorly understood. Pain biomarkers could potential…

observational 2021
Urology ·doi:10.1016/j.urology.2021.07.009

OBJECTIVE: To further examine anesthetic bladder capacity as a biomarker for interstitial cystitis/bladder pain syndrome (IC/BPS) patient subtypes, we evaluated demographic and clinical characteristics in a large and heterogeneous female pa…

other 2017
JAMA oncology ·doi:10.1001/jamaoncol.2016.5945

IMPORTANCE: The causal direction and magnitude of the association between telomere length and incidence of cancer and non-neoplastic diseases is uncertain owing to the susceptibility of observational studies to confounding and reverse causa…

observational 2013
PloS one ·doi:10.1371/journal.pone.0069404

Protein tyrosine phosphatase non-receptor type 22 (PTPN22) is a negative regulator of T-cell activation associated with several autoimmune diseases, including systemic lupus erythematosus (SLE). Missense rs2476601 is associated with SLE in …